Antibody molecules having specificity for human IL-1beta

Details for Australian Patent Application No. 2004210776 (hide)

Owner UCB Pharma S.A.

Inventors Lawson, Alastair David Griffiths; Popplewell, Andrew George

Agent Watermark

Pub. Number AU-B-2004210776

PCT Pub. Number WO2004/072116

Priority 0303337.0 13.02.03 GB

Filing date 6 February 2004

Wipo publication date 26 August 2004

Acceptance publication date 7 April 2011

International Classifications

C07K 16/24 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

C12N 15/13 (2006.01) Mutation or genetic engineering - Immunoglobulins

Event Publications

1 September 2005 PCT application entered the National Phase

  PCT publication WO2004/072116 Priority application(s): WO2004/072116

14 February 2008 Assignment before Grant

  Celltech R&D Limited The application has been assigned to UCB Pharma S.A.

7 April 2011 Application Accepted

  Published as AU-B-2004210776

4 August 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004210779-Isoxazole compounds as inhibitors of heat shock proteins

2004210775-An electrostatic atomiser